VRPX - Virpax Pharmaceuticals GAAP EPS of -$0.51 November, 15 2023 06:02 PM Virpax Pharmaceuticals Inc. 2023-11-15 18:02:42 ET Virpax Pharmaceuticals press release ( NASDAQ: VRPX ): Q3 GAAP EPS of -$0.51. As of September 30, 2023, cash and cash equivalents were $12.2 million. For further details see: Virpax Pharmaceuticals GAAP EPS of -$0.51